TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34393491

Group type: EXPERIMENTAL
Intervention: 4As model (facility-based counseling)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 4As + R model (home-based counseling)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Supportive activities (non-delivery cost)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Overall cost per smoker
Number of subjects: 0
Study: 33129099

Group type: EXPERIMENTAL
Intervention: Nano-curcumin
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 35389288

Group type: EXPERIMENTAL
Intervention: Level 3: Levels 1-2 plus Fitbit and text messages
Number of subjects: 202

Group type: COMPARATOR
Intervention: Level 2: Level 1 plus personalized diet and exercise prescription
Number of subjects: 202

Group type: COMPARATOR
Intervention: Level 1: website
Number of subjects: 202

Group type: COMPARATOR
Intervention: Level 4: Levels 1-3 plus 2 30-minute coaching calls
Number of subjects: 202
Study: 32898698

Group type: EXPERIMENTAL
Intervention: Ketamine-lidocaine group (0.5 mg/kg ketamine plus 1 mg/kg lidocaine)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Ketamine group (1 mg/kg ketamine)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Ketamine-lidocaine group
Number of subjects: 44

Group type: COMPARATOR
Intervention: Ketamine group
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 44
Study: 32947595

Group type: EXPERIMENTAL
Intervention: Volar locking plate fixation
Number of subjects: 166

Group type: COMPARATOR
Intervention: External fixation
Number of subjects: 166
Study: 35104171

Group type: EXPERIMENTAL
Intervention: My Life After Stroke (MLAS) self-management programme
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: MLAS self-management programme
Number of subjects: 17
Study: 33894834

Group type: EXPERIMENTAL
Intervention: Sonelokimab 30 mg
Number of subjects: 313

Group type: EXPERIMENTAL
Intervention: Sonelokimab 60 mg
Number of subjects: 313

Group type: EXPERIMENTAL
Intervention: Sonelokimab 120 mg normal load
Number of subjects: 313

Group type: EXPERIMENTAL
Intervention: Sonelokimab 120 mg augmented load
Number of subjects: 313

Group type: EXPERIMENTAL
Intervention: Secukinumab 300 mg
Number of subjects: 313

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 313
Study: 34051117

Group type: EXPERIMENTAL
Intervention: Transesophageal echocardiography during coronary artery bypass graft surgery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 33310293

Group type: EXPERIMENTAL
Intervention: Neoadjuvant systemic therapy (NST)
Number of subjects: 206

Group type: COMPARATOR
Intervention: Standard neoadjuvant treatment or experimental treatment modified according to interim Ki-67 evaluation
Number of subjects: 206
Study: 32066739

Group type: EXPERIMENTAL
Intervention: Active rTMS (1 Hz)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 0
Study: 36180158

Group type: EXPERIMENTAL
Intervention: Balance training with gaze stabilization exercises
Number of subjects: 64

Group type: COMPARATOR
Intervention: Balance training with saccade eye exercises (control group)
Number of subjects: 64
Study: 34506240

Group type: EXPERIMENTAL
Intervention: Codeine 30 mg/acetaminophen 325 mg every 4 hours as needed for severe pain for 4 days
Number of subjects: 200

Group type: COMPARATOR
Intervention: Oxycodone 5 mg/acetaminophen 325 mg every 4 hours as needed for severe pain for 4 days
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Both groups (codeine and oxycodone)
Number of subjects: 200
Study: 34246994

Group type: EXPERIMENTAL
Intervention: Endoscopic surgery
Number of subjects: 1118

Group type: COMPARATOR
Intervention: Microscopic surgery
Number of subjects: 1118
Study: 33092705

Group type: EXPERIMENTAL
Intervention: MitraClip implantation
Number of subjects: 613

Group type: COMPARATOR
Intervention: Guideline-directed medical therapy (GDMT)
Number of subjects: 613
Study: 35265234

Group type: EXPERIMENTAL
Intervention: UTVOR (volatile oil of Olibanum and volatile oil of Chuanxiong Rhizoma with ultrasound therapy)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Conventional ultrasound therapy
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: UTVOR
Number of subjects: 116
Study: 36197757

Group type: EXPERIMENTAL
Intervention: Ozoralizumab 30 mg
Number of subjects: 381

Group type: EXPERIMENTAL
Intervention: Ozoralizumab 80 mg
Number of subjects: 381

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 381

Group type: EXPERIMENTAL
Intervention: Ozoralizumab 30 mg and 80 mg
Number of subjects: 381
Study: 32048133

Group type: EXPERIMENTAL
Intervention: High lactate levels (≥ 2 mmol/l)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Low lactate levels (< 2 mmol/l)
Number of subjects: 85
Study: 33322963

Group type: EXPERIMENTAL
Intervention: Intervention group received directly observed therapy of asthma controller medication, medication adjustments, and daily self-management support.
Number of subjects: 29

Group type: COMPARATOR
Intervention: Usual care group referred back to primary care provider for routine asthma care.
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Both groups had significant improvements in Asthma Control Test scores from baseline to 7 month follow-up (both p <.01).
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 29
Study: 32602552

Group type: EXPERIMENTAL
Intervention: AGGF1 expression in preeclamptic placentas
Number of subjects: 28

Group type: COMPARATOR
Intervention: AGGF1 expression in normotensive control placentas
Number of subjects: 28
Study: 36266396

Group type: EXPERIMENTAL
Intervention: tDCS (right DLPFC anodal stimulation)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Neurofeedback (Sensorimotor Rhythm protocol)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Active neuromodulation (tDCS or neurofeedback)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Sham neuromodulation (placebo)
Number of subjects: 80
Study: 34051009

Group type: EXPERIMENTAL
Intervention: Gut microbiota profile analysis using 16S rRNA gene sequencing in high-risk group (men with Grade group 2 or higher PCa)
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Index calculated from the abundance of 18 bacterial genera
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Validation of the index in the test cohort
Number of subjects: 152
Study: 34772609

Group type: EXPERIMENTAL
Intervention: Chemotherapy (capecitabine, oxaliplatin added an investigator's choice)
Number of subjects: 231

Group type: COMPARATOR
Intervention: Follow-up (control group)
Number of subjects: 231
Study: 34162198

Group type: EXPERIMENTAL
Intervention: 0.12% chlorhexidine gluconate mouthrinse gargled for 1 minute before EBUS‐TBNA
Number of subjects: 112

Group type: COMPARATOR
Intervention: No mouthrinse before EBUS‐TBNA
Number of subjects: 112
Study: 33157007

Group type: EXPERIMENTAL
Intervention: Rapid genomic sequencing (RGS)
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Ultra-rapid whole-genome sequencing (urWGS)
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Positive tests
Number of subjects: 201
Study: 34126264

Group type: EXPERIMENTAL
Intervention: Ketamine (0.5 mg/kg)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 33793609

Group type: EXPERIMENTAL
Intervention: Vestibular rehabilitation with virtual reality using the Wii® console, Wii-Remote and Wii Balance Board, performing balance games for 30 minutes to an hour, twice a week for 10 weeks (total: 20 sessions).
Number of subjects: 40

Group type: COMPARATOR
Intervention: Vestibular rehabilitation with virtual reality using the Wii® console, Wii-Remote and Wii Balance Board, performing balance games and muscle strength games for 30 minutes to an hour, twice a week for 10 weeks (total: 20 sessions).
Number of subjects: 40
Study: 34010932

Group type: EXPERIMENTAL
Intervention: Pegteograstim
Number of subjects: 32
Study: 32343641

Group type: EXPERIMENTAL
Intervention: Dexrazoxane
Number of subjects: 1014
Study: 35949961

Group type: EXPERIMENTAL
Intervention: Pulsed electromagnetic field (PEMF) therapy (8 Hz, 3.2 mT) in addition to a conventional rehabilitation program
Number of subjects: 32

Group type: COMPARATOR
Intervention: Conventional rehabilitation program (physical modalities, exercises, and occupational therapy)
Number of subjects: 32
Study: 34028859

Group type: EXPERIMENTAL
Intervention: Nurse-led dietary diabetes insipidus (DI) bundle
Number of subjects: 50
Study: 33949332

Group type: EXPERIMENTAL
Intervention: Internal stenting of the pancreaticojejunostomy anastomosis (Group B)
Number of subjects: 50

Group type: COMPARATOR
Intervention: No internal stenting of the pancreaticojejunostomy anastomosis (Group A)
Number of subjects: 50
Study: 33078386

Group type: EXPERIMENTAL
Intervention: Fenfluramine at 0.2 mg/kg/d, titrated to a maximum of 0.7 mg/kg/d (or 0.4 mg/kg/d with stiripentol)
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: Fenfluramine
Number of subjects: 232
Study: 34152940

Group type: EXPERIMENTAL
Intervention: Coping with Work and Family Stress (CWFS) evidence‐based curriculum
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no programming)
Number of subjects: 0
Study: 33511717

Group type: EXPERIMENTAL
Intervention: Analysis of amino acid sequence and local structure relationships
Number of subjects: 4000
Study: 616517889

Group type: EXPERIMENTAL
Intervention: High-pitch spiral dual-source CT acquisition (group A)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Retrospectively gated spiral dual-source CT acquisition (group B)
Number of subjects: 50
Study: 32267588

Group type: EXPERIMENTAL
Intervention: image‐and‐text HWL
Number of subjects: 6024

Group type: EXPERIMENTAL
Intervention: image‐only HWL
Number of subjects: 6024

Group type: EXPERIMENTAL
Intervention: text‐only HWL
Number of subjects: 6024

Group type: COMPARATOR
Intervention: no HWL
Number of subjects: 6024
Study: 34252783

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral treatment for youth with co-occurring mental health and substance use concerns
Number of subjects: 110
Study: 32736330

Group type: EXPERIMENTAL
Intervention: Computerised decision support systems (CDSSs)
Number of subjects: 29
Study: 35124650

Group type: EXPERIMENTAL
Intervention: CSF markers of CNS barrier disruption, cerebrovascular dysfunction, CSF inflammatory cytokines, blood lipid profiles
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Blood lipid profiles
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Machine learning prediction model
Number of subjects: 0
Study: 34999143

Group type: EXPERIMENTAL
Intervention: Retroactive memory interference (RI) group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Guilty group (both RI and control)
Number of subjects: 0
Study: 33977687

Group type: EXPERIMENTAL
Intervention: Arjun Chāl (Terminalia arjuna) 5 gm BD for 8 weeks
Number of subjects: 48

Group type: COMPARATOR
Intervention: Amlodipine (5 mg) and Atorvastatin (10 mg) once a day for 8 weeks
Number of subjects: 48
Study: 35254473

Group type: EXPERIMENTAL
Intervention: Laser (LS)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Radiofrequency (RF)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Sham Control (SCT)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Laser (LS) and Radiofrequency (RF)
Number of subjects: 114
Study: 32143674

Group type: EXPERIMENTAL
Intervention: Adaptive conjunctive cognitive training (ACCT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard cognitive tasks (Control)
Number of subjects: 30
Study: 34248001

Group type: EXPERIMENTAL
Intervention: 1% chlorhexidine gel treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 0
Study: 33417897

Group type: EXPERIMENTAL
Intervention: Prophylactic hemoclip application
Number of subjects: 204

Group type: COMPARATOR
Intervention: Control (no pretreatment)
Number of subjects: 204
Study: 32219973

Group type: EXPERIMENTAL
Intervention: GI2 kHz/2 Hz
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: GI4 kHz/2 Hz
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: GI4 kHz/100 Hz
Number of subjects: 175

Group type: COMPARATOR
Intervention: Placebo group (PG)
Number of subjects: 175
Study: 35793884

Group type: EXPERIMENTAL
Intervention: Acupuncture combined with western medication
Number of subjects: 60

Group type: COMPARATOR
Intervention: Western medication
Number of subjects: 60
Study: 34279749

Group type: EXPERIMENTAL
Intervention: Fixed combination carteolol/latanoprost (LCFC)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Timolol/latanoprost (LTFC)
Number of subjects: 22
Study: 35970016

Group type: EXPERIMENTAL
Intervention: 1,2,3,emoció! program
Number of subjects: 2625

Group type: COMPARATOR
Intervention: Comparison group (control)
Number of subjects: 2625
Study: 34383762

Group type: EXPERIMENTAL
Intervention: Multi-component school-based intervention to prevent intimate partner violence
Number of subjects: 3743

Group type: EXPERIMENTAL
Intervention: Low family socio-economic status (SES)
Number of subjects: 3743

Group type: EXPERIMENTAL
Intervention: Learner behavior, home environment, and school environment
Number of subjects: 3743
Study: 34322126

Group type: EXPERIMENTAL
Intervention: Peptide pools derived from HCMV
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Peptide pools derived from HAdV
Number of subjects: 48
Study: 32015461

Group type: EXPERIMENTAL
Intervention: AVL-3288 (10 mg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: AVL-3288 (30 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 35697217

Group type: EXPERIMENTAL
Intervention: Trailbridges
Number of subjects: 147
Study: 33626615

Group type: EXPERIMENTAL
Intervention: HIV/syphilis joint self‐testing group
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Lottery incentive self‐testing group
Number of subjects: 145

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 145
Study: 32665162

Group type: EXPERIMENTAL
Intervention: Tolvaptan + Furosemide
Number of subjects: 40

Group type: COMPARATOR
Intervention: Furosemide
Number of subjects: 40
Study: 36301170

Group type: EXPERIMENTAL
Intervention: Acupotomy
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Warm needling
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Combined treatment (acupotomy + warm needling)
Number of subjects: 90
Study: 34936267

Group type: EXPERIMENTAL
Intervention: Horizontal penetration needling at vertigo auditory area and balance area (treatment given once every other day for two courses of treatment)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group (no acupuncture and medication)
Number of subjects: 66
Study: 33969800

Group type: EXPERIMENTAL
Intervention: Clinical depression
Number of subjects: 2608

Group type: EXPERIMENTAL
Intervention: Distress
Number of subjects: 2608

Group type: EXPERIMENTAL
Intervention: Suicidal thoughts
Number of subjects: 2608

Group type: EXPERIMENTAL
Intervention: Self-reported anxiety, depressive thoughts, suicidal ideation, and being currently depressed/distressed
Number of subjects: 2608

Group type: EXPERIMENTAL
Intervention: Protective factors
Number of subjects: 2608
Study: 35742754

Group type: EXPERIMENTAL
Intervention: Interleaved micro‐lectures by both perceptual modality and subject matter (I-all condition)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Blocked micro‐lectures with auditory textual information (B-A condition)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Blocked micro‐lectures with visual textual information (B-V condition)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Interleaved micro‐lectures with auditory textual information (I-A condition)
Number of subjects: 81
Study: 34037290

Group type: EXPERIMENTAL
Intervention: Midazolam (0.1 mg/kg)
Number of subjects: 100
Study: 33244344

Group type: EXPERIMENTAL
Intervention: Maternal Health Services (MHS) utilization
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Perception of stigmatisation
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: MHS utilization based on marital status
Number of subjects: 212

Group type: COMPARATOR
Intervention: MHS utilization and maternal education
Number of subjects: 212

Group type: COMPARATOR
Intervention: MHS utilization and availability/accessibility of MHS facilities
Number of subjects: 212

Group type: COMPARATOR
Intervention: MHS utilization and cost of MHS
Number of subjects: 212

Group type: COMPARATOR
Intervention: MHS utilization and coercion/violence from partner
Number of subjects: 212
Study: 32238301

Group type: EXPERIMENTAL
Intervention: Conventional RGP CL
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Kerasoft CL
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Rose K2 CL
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Scleral RGP CL
Number of subjects: 28

Group type: COMPARATOR
Intervention: Spectacles
Number of subjects: 28

Group type: COMPARATOR
Intervention: Controls (10 age‐matched controls)
Number of subjects: 28
Study: 36138354

Group type: EXPERIMENTAL
Intervention: Goggles + surgical mask
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Face shield + surgical mask
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Half‐face respirator
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Full‐face respirator
Number of subjects: 52

Group type: COMPARATOR
Intervention: Conventional PPE (goggles + surgical mask, face shield + surgical mask)
Number of subjects: 52
Study: 32554067

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (1 μg/kg bolus over 10 minutes, followed by 0.5 μg/kg per hour maintenance) with midazolam (0.03 mg/kg)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Propofol (125 μg/kg per minute infusion over 10 minutes with intraoperative boluses of 0.1 μg/kg) and fentanyl (0.8 μg/kg) with midazolam (0.03 mg/kg)
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine and midazolam
Number of subjects: 141

Group type: COMPARATOR
Intervention: Propofol, fentanyl, and midazolam
Number of subjects: 141
Study: 32543980

Group type: EXPERIMENTAL
Intervention: Intralesional cryotherapy (ILC)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Cryotherapy spray (Cryo‐sp)
Number of subjects: 130
Study: 32267071

Group type: EXPERIMENTAL
Intervention: Basal insulin analog (BI)
Number of subjects: 814

Group type: EXPERIMENTAL
Intervention: Mid-mixture insulin analog (MMI)
Number of subjects: 814

Group type: COMPARATOR
Intervention: Both BI and MMI
Number of subjects: 814
Study: 34255891

Group type: EXPERIMENTAL
Intervention: Apremilast 30 mg BID
Number of subjects: 1062
Study: 32146698

Group type: EXPERIMENTAL
Intervention: Specific mobility and falls prevention class
Number of subjects: 780

Group type: EXPERIMENTAL
Intervention: DXA scan
Number of subjects: 780
Study: 34348792

Group type: EXPERIMENTAL
Intervention: Low-load resistance training combined with blood flow restriction (LRT-BFR)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: High-load resistance training (CRT)
Number of subjects: 51

Group type: COMPARATOR
Intervention: No-strength training control
Number of subjects: 51
Study: 33086512

Group type: EXPERIMENTAL
Intervention: Nutritionally complete, high-protein diet for 6 months
Number of subjects: 74
Study: 34051428

Group type: EXPERIMENTAL
Intervention: Flaxseed oil (4 g ALA/day)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Fish oil (4 g DHA + 0.8 g EPA/day)
Number of subjects: 24
Study: 35857936

Group type: EXPERIMENTAL
Intervention: Billroth I anastomosis
Number of subjects: 108

Group type: COMPARATOR
Intervention: Billroth II combined with Braun anastomosis
Number of subjects: 108

Group type: COMPARATOR
Intervention: Roux-en-Y anastomosis
Number of subjects: 108
Study: 33531271

Group type: EXPERIMENTAL
Intervention: Ultrasound imaging (US) for echo-intensity measures
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Ultrasound imaging (US) for morphological measures
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Ultrasound imaging (US) for cross-sectional area (CSA) and perimeter measures
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Ultrasound imaging (US)
Number of subjects: 25
Study: 36183308

Group type: EXPERIMENTAL
Intervention: Anti-inflammatory accompanied by a low-calorie diet
Number of subjects: 60
Study: 33973917

Group type: EXPERIMENTAL
Intervention: 5% povidone-iodine
Number of subjects: 100

Group type: COMPARATOR
Intervention: Artificial tears
Number of subjects: 100
Study: 35471192

Group type: EXPERIMENTAL
Intervention: Exercise + nutrient-dense energy restriction of 500 kcal/d group
Number of subjects: 163

Group type: COMPARATOR
Intervention: Exercise + nutrient-dense weight maintenance group
Number of subjects: 163

Group type: COMPARATOR
Intervention: Exercise only group
Number of subjects: 163
Study: 35313751

Group type: EXPERIMENTAL
Intervention: Aerobic training program
Number of subjects: 257

Group type: COMPARATOR
Intervention: Usual rehabilitation care guideline recommended
Number of subjects: 257
Study: 32138809

Group type: EXPERIMENTAL
Intervention: Uterine preservation
Number of subjects: 771

Group type: COMPARATOR
Intervention: Vaginal hysterectomy
Number of subjects: 771

Group type: EXPERIMENTAL
Intervention: Abdominal procedure
Number of subjects: 771

Group type: COMPARATOR
Intervention: Vaginal procedure
Number of subjects: 771
Study: 35320135

Group type: EXPERIMENTAL
Intervention: EMG-controlled games training (unilateral or bilateral)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 20
Study: 33685838

Group type: EXPERIMENTAL
Intervention: MDT (stereotactic ablative body radiotherapy [SABR] or surgery) without HT
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: MDT (surgery)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: MDT (SABR)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: MDT
Number of subjects: 72
Study: 35623756

Group type: EXPERIMENTAL
Intervention: Diabetes Community Exercise and Education Programme (DCEP) - twice weekly sessions of exercise and education over 12 weeks, followed by ongoing exercise classes.
Number of subjects: 31
Study: 32620379

Group type: EXPERIMENTAL
Intervention: Bee-Humming Breathing (BHB) exercise
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo slow breathing exercise
Number of subjects: 70
Study: 35907490

Group type: EXPERIMENTAL
Intervention: Standard daily dosing of vitamin D
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Loading doses followed by standard daily dosing of vitamin D
Number of subjects: 0
Study: 34423510

Group type: EXPERIMENTAL
Intervention: Combination group treated with 30% GA peel at 2 weekly intervals with 5% TXA solution applied twice daily
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group treated with only 30% GA peel every 2 weeks for 12 weeks
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60